Aisel Health, a Copenhagen-based HealthTech company building an operating system (OS) purpose-built for psychiatry and mental health, today announced it has closed a €1.7 million pre-Seed round.
The round was led by Caesar Ventures, with participation from Nordic Web Ventures, LifeX, and Angel Invest, alongside existing investors Rockstart and EIFO.
“Psychiatry doesn’t need more generic technology bolted onto an already overburdened workflow. It needs a product built around the realities of psychiatric care – where clinicians bring judgment, empathy, and years of trained intuition, and the technology brings the speed, structure, and ability to hold together every detail about every patient, in a way no human memory can,” said Augusta Klingsten Peytz, co-founder and CEO of Aisel Health.
Founded in 2024 by Peytz and Christian Houen, Aisel Health builds software that helps psychiatric clinics scale their operations by surfacing the right information for clinicians at the right time. The company states that it improves the patient experience, reduces strain on staff, and increases clinic profitability.
According to Aisel Health, although AI note-taking tools have emerged to ease the burden on overworked clinicians, faster notes create a different problem. As documentation becomes cheaper and quicker to produce, the information inside it becomes harder to find. It notes that with patient records accumulating across different systems and over time, the challenge shifts from writing notes to finding relevant information.
The company cites its latest research, “The Documentation Minute”, which found that psychiatrists spend far longer on evidence-gathering than on writing the note itself — pulling together a patient’s history from referrals, prior notes, and multiple systems before they can even begin to assess and treat.
“AI scribes work – they write notes faster, and that’s great for immediate burnout. But that’s not what’s keeping waiting lists long. Make notes cheaper to produce, and you just make that information harder to find when a clinician needs it. We still have yet to overcome the human limitation of understanding everything that was ever written about every patient ever treated – that’s the problem we built Aisel to solve: giving clinicians exactly what they need, when and how they need it,” said Christian Houen, co-founder and CPO of Aisel Health.
Aisel Health claims that its platform reduces the documentation burden and surfaces the clinical history and context a psychiatrist needs, when and how they need it. It turns interview recordings, existing documents and the patient’s own accounts into structured, contextual insights relevant to whatever moment the clinician is in. Before, during, and after the consultation, Aisel provides direct insight into all documentation regarding the patient.
Highlighting the company’s security and compliance features, it states that it does not have access to patients’ medical records and that patient data is never used to train its AI models. It also states that all data is stored and processed on secure servers within Europe, in line with GDPR and local data protection regulations.
“Few problems in healthcare are as large or as overlooked as psychiatry’s, and few founders are as passionate about solving it the way Augusta and Christian are. We’re proud to lead this round, and look forward to supporting them to deliver the next generation of technology for psychiatry,” said Carolin Gabor, Managing Partner and GP at Caesar Ventures.
The company plans to use this funding to grow its clinical and engineering teams and fund its UK market entry, converting an active commercial pipeline in private psychiatry, ahead of a planned Seed round.
